JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: CP-466722 is a novel, specific and reversible ATM inhibitor with an IC50 value of 4.1 uM, it does not affect ATR and inhibits PI3K or PIKK family members in cells. Inhibition of cellular ATM kinase activity was rapidly and completely reversed by removing CP466722. CP-466722 is regarded as a promising drug to increase tumor cells sensitivity to IR. When tested with Hela, MCF-7 and mouse cells pre-treated with IR which induced the increase in ATM-dependent phosphorylation events and then CP-466722 treatment resulted in the disruption of ATM-dependent phosphorylation events and inhibiton of ATM-dependent p53 inducetion at the minimal dose of 6 uM.
References: Cancer Res. 2008 Sep 15; 68(18):7466-74; J Biomol Screen. 2014 Apr; 19(4):538-46.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Recommend by mail
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!